MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$8,806K
Net Income
-$16,157K
Net Profit Margin
-183.48%
EPS
-$0.13
Unit: Thousand (K) dollars
Revenue Breakdown
License And Other Revenue
Product
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
8,806
2,708
2,568
1,765
Cost of revenue
1,617
598
364
351
Research and development
15,079
15,450
18,521
17,337
General and administrative
8,501
6,966
7,382
11,586
Gain on sale of non-financial asset
-
-
0
0
Total operating expense
-25,197
-23,014
-26,267
-29,274
Loss from operations
-16,391
-20,306
-23,699
-27,509
Interest income
1,979
2,105
1,985
901
Interest expense
2,164
2,134
2,186
2,257
Change in fair value of warrant liability
528
80
-18
-676
Other income, net
-107
14
-7
-304
Total other income, net
236
65
-226
-2,336
Loss before provision for income taxes
-16,155
-20,241
-23,925
-29,845
Provision for income taxes
2
0
0
-30
Net loss
-16,157
-20,241
-23,925
-29,815
Basic EPS
-0.13
-0.16
-0.566
-0.69
Diluted EPS
-0.13
-0.16
-0.566
-0.69
Basic Average Shares
126,344,020
126,288,723
42,292,818*
43,272,773
Diluted Average Shares
126,344,020
126,288,723
42,292,818*
43,272,773
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$16,157K
(37.23%↑ Y/Y)
Interest income
$1,979K
(197.59%↑ Y/Y)
Change in fair value of
warrant liability
$528K
(-80.02%↓ Y/Y)
Loss before
provision for income taxes
-$16,155K
(37.15%↑ Y/Y)
Provision for income taxes
$2K
(-94.59%↓ Y/Y)
Total other income,
net
$236K
(-55.30%↓ Y/Y)
License And Other
Revenue
$6,433K
Product
$2,373K
Interest expense
$2,164K
(-3.05%↓ Y/Y)
Other income, net
-$107K
(80.44%↑ Y/Y)
Loss from operations
-$16,391K
(37.52%↑ Y/Y)
Total revenue
$8,806K
(346.33%↑ Y/Y)
Total operating
expense
-$25,197K
(10.66%↑ Y/Y)
Research and development
$15,079K
(-17.83%↓ Y/Y)
General and
administrative
$8,501K
(-10.77%↓ Y/Y)
Cost of revenue
$1,617K
(396.01%↑ Y/Y)
Buy us a coffee
X4 Pharmaceuticals, Inc (XFOR)
X4 Pharmaceuticals, Inc (XFOR)